Navigation Links
The Future is Bright for Formedix, Leading Clinical Trial Software Provider

Burlington, MA (PRWEB) November 26, 2013

2013 has been a busy but exciting year for Formedix, the leading provider of clinical trial automation tools, as the company entered into and has continued in a period of extreme growth, across multiple areas.

The company’s workforce has grown by over 50% since Q1 2013 and is divided across US and UK office locations. With the ever-increasing numbers, the company has moved to a bigger UK office location in Glasgow’s city centre, which was announced towards the end of October 2013. The new premises have allowed Formedix to, not only expand across all departments, but to also accommodate customers more effectively and efficiently with investment in new resources and even better facilities. Formedix is headquartered in Burlington, MA.

Formedix also recently launched a brand new website introducing a fresh new look, improved site navigation for users, a greater focus on content delivery and the newest feature, ‘The Formedix Clinic’ blog. The Formedix Clinic allows visitors to “drop in and catch up on the latest news and standards knowledge.” This latest addition will allow the expert bloggers to share their views on various topics that are of interest to them, as well as creating talking points and encouraging discussion within the industry.

There are also exciting times ahead for Formedix with major updates planned for the study design and study execution tools offered by the company. Formedix Origin, the flagship suite of universal study design tools and Formedix Transform, a range of vendor neutral study execution tools, will soon be merged into one greater, more accessible platform. Formedix will continue to work with market leading technology partners to offer unique integrations between Formedix and partners’ market-leading Electronic Data Capture (EDC) solutions. There will be more updates of the platform’s progress coming from Formedix in 2014.

Formedix Chairman, Douglas Milton says,”As someone who has been involved with the company for a number of years, it is always good to know the future is bright at Formedix but it is even more exciting to see all these great changes and new additions. I am really looking forward to seeing the results as new team members are introduced and major product updates are made.”

Contact Formedix for more information about the universal design and build tools, or to express an interest in partnering with the company.

Read the full story at

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. Biohack Pure’s Jonathan Weisman Predicts the Future of Smart Drugs
2. The Market for Primary Cells & Stem Cell-Derived Cells: Current and Future Opportunities
3. International Collaboration Puts the Future of Healthcare IT on Display at the University City Science Center
4. Moving from Treatment to Management: MassDevice Focuses On Chronic Diseases and the Future Business Model of Med-tech at the 2013 Big 100 West
5. The Future of Amyloid Detection
6. The Future of Brazil Tobacco and Tobacco Products Packaging to 2017
7. Electronic Health Records: Charting the Future of Health Care - 2013 Report
8. Bright Future Ahead for Biopharmaceutical Contract Manufacturing, Says Frost & Sullivan
9. Polyhydroxyalkanoate Demand to Grow Significantly in Future, According to M&M Study Published at
10. Green future development: Top 10 priorities for emerging economy countries
11. Investigational Diabetes Drug May Also Have Future As Treatment for Parkinsons Disease
Post Your Comments:
(Date:11/30/2015)... , Nov. 30, 2015 /PRNewswire/ - Zenith Epigenetics Corp. ("Zenith" ... Norman C.W. Wong to its Board of Directors ... to Zenith with a wealth of experience as co-founder of ... biology. --> --> Dr. ... Epigenetics, board of directors. Zenith,s long standing expertise in epigenetics ...
(Date:11/30/2015)... 2015  Champions Oncology, Inc. (CSBR), engaged in the ... the development and use of oncology drugs, today announced ... be presenting at the LD MICRO Investor Conference on ... (PST).  The conference, held at the Luxe Sunset Bel ... , will feature 200 small/micro-cap companies and is expected ...
(Date:11/30/2015)... Nov. 30, 2015  HUYA Bioscience International, the leader ... pharmaceutical innovations, today announced it has signed a ... (KDDF) to foster collaboration between KDDF and HUYA with ... of healthcare products for the global market. ... source of new innovative preclinical and clinical stage compounds. ...
(Date:11/30/2015)... and MAGDEBURG, Germany , November ... NeuroRehabilitation (ECNR) in Vienna, Austria ... European Congress of NeuroRehabilitation (ECNR) in Vienna, ... --> NovaVision, a wholly owned subsidiary of Vycor Medical, ... version of its Internet-delivered NovaVision Therapy Suite at the ...
Breaking Biology Technology:
(Date:11/12/2015)... CAMBRIDGE, Mass. , Nov. 12, 2015 /PRNewswire/ ... Broad Institute of MIT and Harvard for use ... chemical discovery information management tools. The partnership will ... share both biological and chemical research information internally ... tools will be used for managing the Institute,s ...
(Date:11/10/2015)... NEW YORK , Nov. 10, 2015 /PRNewswire/ ... refers to behavioral biometrics that helps to identify ... prevent fraud. Signature is considered as the secure ... for the identification of a particular individual because ... offers more accurate results especially when dynamic signature ...
(Date:11/2/2015)... , Nov. 2, 2015  SRI International has ... to provide preclinical development services to the National Cancer ... SRI will provide scientific expertise, modern testing and support ... of preclinical pharmacology and toxicology studies to evaluate potential ... --> The PREVENT Cancer Drug Development Program is ...
Breaking Biology News(10 mins):